Jerome Powell, who once assured us that inflation was “transitory,” is trying to protect not only the economy, but also his reputation. Read More
Analyst Articles
The first two months of 2023 have seen the introduction of several new bills to legalize psychedelics, especially psilocybin. Read More
Investors got clobbered last year, and so far in 2023 stocks have been volatile and frustrating. But here’s why you should stay in the game. Read More
Hotter-than-expected inflation reports have dashed odds that the Fed will soon ease up on tightening, all of which has fueled bearishness. Read More
The personal consumption expenditures price index came in hotter than expected for January, which puts the 2023 equity rally in jeopardy. Read More
Most artificial intelligence players are giant household names with diversified segments, but AI is the sole focus of this mid-cap company. Read More
Nine states are showing a high probability of legalizing adult-use cannabis by 2030, while another nine are likely to legalize medical weed. Read More
Our editorial director interviews financial guru Robert Rapier about the investment opportunities and risks in the year ahead. Read More
The stock market has become a minefield, as companies that beat earnings expectations see their shares drop anyway. Read More
International markets are rebounding, which makes overseas dividend payers attractive. This global dividend ETF is flashing “buy.” Read More